Cognigenics
Fabio Macciardi is currently the Chief Scientific Officer at Cognigenics and holds the position of Professor of Molecular Psychiatry (emeritus) at the University of California, Irvine, where a laboratory has been headed since 2009. Macciardi specializes in the analysis of gene function and evolution related to neurocognitive traits, employing advanced DNA, RNA sequencing, and brain imaging techniques. Additional roles include serving as a Neurogenetics Scientific Advisor for Vivera Pharmaceuticals, a consultant for Pharnext, and a past consultant for TEVA Pharmaceutical Industries. Previous academic positions include Associate Professor of Medical Genetics at the University of Milan and senior scientist roles at CAMH and the Centre for Addiction and Mental Health. Education includes a medical degree from the Università degli Studi di Milano, a PhD in psychiatric genetics from Università di Catania, and post-doctoral studies in human genetics at Yale School of Medicine.
This person is not in any teams
This person is not in any offices
Cognigenics
Cognigenics transforms mental health in the genetic age through cognitive neuroengineering. The company’s business is cognitive neuroengineering, which is the genetic engineering of desirable cognitive traits, such as mindfulness, relaxation, and mental acuity. These cognitive assets can enhance human performance in normal individuals or offsetcognitive deficits in people suffering from mental health issues such as stress, anxiety, and depression (which are the initial applications).